Cardiomyocyte death: mechanisms and translational implications
暂无分享,去创建一个
A. Criollo | Dian J. Cao | Joseph A. Hill | M. Chiong | R. Troncoso | S. Lavandero | Z. Pedrozo | Zhao V. Wang | A Criollo | Z. Wang | D. Cao | M. Ibacache | A. Nemchenko | J. Hill | M Chiong | Z V Wang | Z Pedrozo | D J Cao | R Troncoso | M Ibacache | A Nemchenko | J A Hill | S Lavandero | Rodrigo Troncoso | Mario Chiong | Alfredo Criollo | Sergio Lavandero | Zhao V. Wang | Dian J. Cao | Mauricio Ibacache | Joseph A. Hill | Zhao V. Wang | Dian J. Cao | Mauricio Ibacache | Alfredo Criollo | Joseph A. Hill | Joseph A. Hill
[1] M. Birnbaum,et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.
[2] I. Komuro,et al. Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum–Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload , 2010, Circulation.
[3] R. Kitsis,et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. , 2003, American journal of physiology. Heart and circulatory physiology.
[4] C. Murry,et al. Heart regeneration , 2011, Nature.
[5] O. Alfieri,et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.
[6] Y. Ho,et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.
[7] T. Asano,et al. Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.
[8] W. Kremers,et al. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. , 2008, European heart journal.
[9] C. Szabó,et al. Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. , 2004, Cardiovascular research.
[10] R. D. de Boer,et al. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. , 2011, American journal of physiology. Heart and circulatory physiology.
[11] G Baumgarten,et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Gottlieb,et al. Enhancing Macroautophagy Protects against Ischemia/Reperfusion Injury in Cardiac Myocytes* , 2006, Journal of Biological Chemistry.
[13] M. Colombo,et al. Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. , 2010, Biochimica et biophysica acta.
[14] R. Xavier,et al. A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. , 2010, Developmental cell.
[15] Jianxin Chen,et al. Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. , 2001, American journal of physiology. Cell physiology.
[16] J. Comella,et al. Switch from Caspase-dependent to Caspase-independent Death during Heart Development , 2006, Journal of Biological Chemistry.
[17] Guido Kroemer,et al. Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] A. Feldman,et al. Anti–Tumor Necrosis Factor-&agr; Antibody Limits Heart Failure in a Transgenic Model , 2001, Circulation.
[19] Pierre Croisille,et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.
[20] R. Knight,et al. STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy , 2012, Journal of cellular and molecular medicine.
[21] Tetsuya Watanabe,et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.
[22] P. Kang,et al. Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. , 2010, American journal of physiology. Heart and circulatory physiology.
[23] K. Sliwa,et al. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 2002, The American journal of cardiology.
[24] Dian J. Cao,et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.
[25] Y. Ueda,et al. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. , 2000, Circulation.
[26] M. Crow,et al. Apoptosis Repressor with Caspase Recruitment Domain Protects against Cell Death by Interfering with Bax Activation* , 2004, Journal of Biological Chemistry.
[27] G. Zambetti,et al. Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. , 2006, American journal of physiology. Heart and circulatory physiology.
[28] F. Klocke,et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. , 1999, Journal of molecular and cellular cardiology.
[29] P. Doevendans,et al. Myocyte apoptosis in heart failure. , 2005, Cardiovascular research.
[30] W. Manning,et al. Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice , 2003, Circulation.
[31] J. Gardin,et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. , 2004, Journal of the American College of Cardiology.
[32] R. Kitsis,et al. Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.
[33] E. Chung,et al. Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial , 2003, Circulation.
[34] Pablo E. Morales,et al. [Mitochondrial dynamics: a potential new therapeutic target for heart failure]. , 2011 .
[35] R. Kitsis,et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.
[36] T. Mak,et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.
[37] D. Offen,et al. Bax deficiency reduces infarct size and improves long-term function after myocardial infarction , 2007, Cell Biochemistry and Biophysics.
[38] J. McMurray,et al. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.
[39] M. Mocanu,et al. The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.
[40] Lin Yan,et al. Autophagy in chronically ischemic myocardium. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Mathur,et al. Stem cell therapy for heart diseases. , 2011, British medical bulletin.
[42] P. Doevendans,et al. Downregulation of Apoptosis-Inducing Factor in Harlequin Mutant Mice Sensitizes the Myocardium to Oxidative Stress–Related Cell Death and Pressure Overload–Induced Decompensation , 2005, Circulation research.
[43] N. Maulik,et al. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.
[44] I. Komuro,et al. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. , 2010, Circulation research.
[45] A. Koretsky,et al. Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .
[46] T. Vanden Berghe,et al. Molecular mechanisms and pathophysiology of necrotic cell death. , 2008, Current molecular medicine.
[47] Yasushi Matsumura,et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress , 2007, Nature Medicine.
[48] M. Hall,et al. Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice , 2011, Circulation.
[49] Y. Ho,et al. Overexpression of BAR attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice , 2007, Biochimica et biophysica acta.
[50] J. Richardson,et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.
[51] Youngil Lee,et al. Role of apoptosis in cardiovascular disease , 2009, Apoptosis.
[52] A. D. Campo,et al. [Mitochondrial dynamics: a potential new therapeutic target for heart failure]. , 2011, Revista espanola de cardiologia.
[53] H. Katus,et al. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. , 2009, Journal of the American College of Cardiology.
[54] A. Quest,et al. Cell death by necrosis, a regulated way to go. , 2008, Current molecular medicine.
[55] H. Fliss,et al. Apoptosis in ischemic and reperfused rat myocardium. , 1996, Circulation research.
[56] K. Mani. Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage , 2008, Heart Failure Reviews.
[57] M. Latronico,et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. , 2010, The Journal of clinical investigation.
[58] Joseph A. Hill,et al. Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury , 2012, Circulation.
[59] B. Sobel,et al. Autophagy in myocardium of murine hearts subjected to ischemia followed by reperfusion , 2010, Histochemistry and Cell Biology.
[60] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.
[61] So Yeong Lee,et al. Adult alveolar epithelial cells express multiple subtypes of voltage-gated K+ channels that are located in apical membrane. , 2003, American journal of physiology. Cell physiology.
[62] John Calvin Reed,et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[63] K. Fukunaga,et al. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. , 2007, European journal of pharmacology.
[64] Cecilia Hidalgo,et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. , 2008, Cardiovascular research.
[65] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[66] B. Rothermel,et al. The complex interplay between mitochondrial dynamics and cardiac metabolism , 2011, Journal of bioenergetics and biomembranes.
[67] U. Pfeifer,et al. Short-term inhibition of cardiac cellular autophagy by isoproterenol. , 1987, Journal of molecular and cellular cardiology.
[68] C. di Loreto,et al. Myocyte death in the failing human heart is gender dependent. , 1999, Circulation research.
[69] Quan Chen,et al. Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. , 2005, Life sciences.
[70] Jeffrey Robbins,et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.
[71] R. Gottlieb,et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy , 2007, Cell Death and Differentiation.
[72] G. Stassi,et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. , 1999, Circulation.
[73] J. Schaper,et al. Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.
[74] B. Bozkurt,et al. Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure , 2001, Circulation.
[75] J. Holtz,et al. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? , 2002, Journal of the American College of Cardiology.
[76] Lorenzo Galluzzi,et al. Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.
[77] M. R. Bergman,et al. Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors. , 1996, The Journal of pharmacology and experimental therapeutics.
[78] T. Hewett,et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.
[79] P. Balakumar,et al. Anti‐Tumour Necrosis Factor‐α Therapy in Heart Failure: Future Directions , 2006 .
[80] M. Bahro,et al. Short-term stimulation by propranolol and verapamil of cardiac cellular autophagy. , 1987, Journal of molecular and cellular cardiology.
[81] E. Weiss,et al. Caloric restriction: powerful protection for the aging heart and vasculature. , 2011, American journal of physiology. Heart and circulatory physiology.
[82] Holly McDonough,et al. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP , 2005, The Journal of cell biology.
[83] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[84] R. Gottlieb,et al. Autophagy in Ischemic Heart Disease , 2009, Circulation research.